Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer.

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.

Cancers (Basel). 2019 May 10;11(5). pii: E648. doi: 10.3390/cancers11050648.

2.

Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases.

Santeufemia DA, Palmieri G, Cossu A, De Re V, Caggiari L, De Zorzi M, Casula M, Sini MC, Baldino G, Dedola MF, Corona G, Miolo G.

Diagnostics (Basel). 2019 Apr 11;9(2). pii: E42. doi: 10.3390/diagnostics9020042.

3.

The metabolomic scent of cancer disease progression in soft tissue sarcoma: A case report.

Miolo G, Basile D, Carretta A, Santeufemia DA, Steffan A, Corona G.

Int J Biol Markers. 2019 Mar 11:1724600818817316. doi: 10.1177/1724600818817316. [Epub ahead of print]

PMID:
30852948
4.

Rapid LC-MS/MS method for quantification of vinorelbine and 4-O-deacetylvinorelbine in human whole blood suitable to monitoring oral metronomic anticancer therapy.

Corona G, Gusella M, Gaspardo A, Miolo G, Bertolaso L, Pezzolo E, Pasini F, Steffan A, Caruso D.

Biomed Chromatogr. 2018 May 10:e4282. doi: 10.1002/bmc.4282. [Epub ahead of print]

PMID:
29749011
5.

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.

Repetto O, Maiero S, Magris R, Miolo G, Cozzi MR, Steffan A, Canzonieri V, Cannizzaro R, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E759. doi: 10.3390/ijms19030759.

6.

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.

Corona G, Cannizzaro R, Miolo G, Caggiari L, De Zorzi M, Repetto O, Steffan A, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E750. doi: 10.3390/ijms19030750.

7.

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

Caggiari L, Miolo G, Buonadonna A, Basile D, Santeufemia DA, Cossu A, Palmieri G, De Zorzi M, Fornasarig M, Alessandrini L, Canzonieri V, Lo Re G, Puglisi F, Steffan A, Cannizzaro R, De Re V.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E47. doi: 10.3390/ijms19010047.

8.

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.

Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V.

Cancer Biol Ther. 2018 Apr 3;19(4):254-259. doi: 10.1080/15384047.2017.1394540. Epub 2017 Nov 13.

9.

Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literature.

Alessandrini L, Sopracordevole F, Bertola G, Scalone S, Urbani M, Miolo G, Perin T, Italia F, Canzonieri V.

Diagn Pathol. 2017 May 2;12(1):36. doi: 10.1186/s13000-017-0627-2. Review.

10.

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.

Miolo G, Muraro E, Caruso D, Crivellari D, Ash A, Scalone S, Lombardi D, Rizzolio F, Giordano A, Corona G.

Oncotarget. 2016 Jun 28;7(26):39809-39822. doi: 10.18632/oncotarget.9489.

11.

Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.

Miolo G, Viel A, Canzonieri V, Baresic T, Buonadonna A, Santeufemia DA, Lara DP, Corona G.

Cancer Biol Ther. 2016 Oct 2;17(10):1017-1021.

12.

Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer.

Toffoli G, Sharma MR, Marangon E, Posocco B, Gray E, Mai Q, Buonadonna A, Polite BN, Miolo G, Tabaro G, Innocenti F.

Clin Cancer Res. 2017 Feb 15;23(4):918-924. doi: 10.1158/1078-0432.CCR-16-1012. Epub 2016 Aug 9.

13.

Gonadal agenesis with hypoplastic paramesonephric ducts (PMNDs) derivatives in dizygotic twins.

Miolo G, Del Pup L, Ash A, Manno M, Pivetta B, Tessitori G, Corona G.

Gynecol Endocrinol. 2016 Oct;32(10):792-795. Epub 2016 Jul 5.

PMID:
27379817
14.

Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.

Cini G, Mezzavilla M, Della Puppa L, Cupelli E, Fornasin A, D'Elia AV, Dolcetti R, Damante G, Bertok S, Miolo G, Maestro R, de Paoli P, Amoroso A, Viel A.

BMC Med Genet. 2016 Feb 6;17:11. doi: 10.1186/s12881-016-0274-6.

15.

Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.

Canzonieri V, Gasparotto D, Alessandrini L, Miolo G, Torrisi E, Perin T, De Paoli P, Maestro R, Buonadonna A.

Pathol Res Pract. 2016 Jan;212(1):63-7. doi: 10.1016/j.prp.2015.11.004. Epub 2015 Nov 10. Review.

PMID:
26616113
16.

Malignant cardiac tumors: diagnosis and treatment.

Lestuzzi C, De Paoli A, Baresic T, Miolo G, Buonadonna A.

Future Cardiol. 2015 Jul;11(4):485-500. doi: 10.2217/fca.15.10. Epub 2015 Aug 3. Review.

PMID:
26235817
17.

Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.

Toffoli G, Giodini L, Buonadonna A, Berretta M, De Paoli A, Scalone S, Miolo G, Mini E, Nobili S, Lonardi S, Pella N, Lo Re G, Montico M, Roncato R, Dreussi E, Gagno S, Cecchin E.

Int J Cancer. 2015 Dec 15;137(12):2971-80. doi: 10.1002/ijc.29654. Epub 2015 Jul 14.

18.

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.

Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R.

BMC Cancer. 2014 Dec 15;14:954. doi: 10.1186/1471-2407-14-954.

19.

Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.

Miolo G, Ash A, Buonadonna A, Lo Re G, Torrisi E, Cervo S, Santeufemia DA, Tuzi A, Canzonieri V.

Cancer Biol Ther. 2014;15(11):1439-43. doi: 10.4161/15384047.2014.956642.

20.

Metabolomics biomarkers of frailty in elderly breast cancer patients.

Corona G, Polesel J, Fratino L, Miolo G, Rizzolio F, Crivellari D, Addobbati R, Cervo S, Toffoli G.

J Cell Physiol. 2014 Jul;229(7):898-902. doi: 10.1002/jcp.24520.

PMID:
24659054

Supplemental Content

Loading ...
Support Center